Bone marrow immune cells and drug resistance in acute myeloid leukemia

被引：0

作者：

Zhang, Miao ^{[1
,2
]}

Yang, You ^{[1
,2
]}

Liu, Jing ^{[1
,2
]}

Guo, Ling ^{[1
,2
]}

Guo, Qulian ^{[1
,2
]}

Liu, Wenjun ^{[1
,2
]}

机构：

[1] Southwest Med Univ, Affiliated Hosp, Dept Pediat Hematol Oncol, Children Hematol Oncol & Birth Defects Lab, Luzhou, Sichuan, Peoples R China

[2] Southwest Med Univ, Sichuan Clin Res Ctr Birth Defects, Affiliated Hosp, Luzhou, Sichuan, Peoples R China

来源：

EXPERIMENTAL BIOLOGY AND MEDICINE | 2025年 / 250卷

关键词：

leukemia; immune cells; drug resistance; bone marrow; immunosuppressive microenvironment; REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; POOR-PROGNOSIS; NK CELLS; AML CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION;

D O I：

10.3389/ebm.2025.10235

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

In recent years, the relationship between the immunosuppressive niche of the bone marrow and therapy resistance in acute myeloid leukemia (AML) has become a research focus. The abnormal number and function of immunosuppressive cells, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), along with the dysfunction and exhaustion of immunological effector cells, including cytotoxic T lymphocytes (CTLs), dendritic cells (DCs) and natural killer cells (NKs), can induce immune escape of leukemia cells and are closely linked to therapy resistance in leukemia. This article reviews the research progress on the relationship between immune cells in the marrow microenvironment and chemoresistance in AML, aiming to provide new ideas for the immunotherapy of AML.

引用

页数：17

共 50 条

[21] Assessment of drug resistance in acute myeloid leukemia
Funato, T
Harigae, H
Abe, S
Sasaki, T
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (05) : 705 - 713
[22] Drug resistance in childhood acute myeloid leukemia
Styczynski, J.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (02) : 59 - 75
[23] Mechanisms of drug resistance in acute myeloid leukemia
Zhang, Jing
Gu, Yan
Chen, Baoan
ONCOTARGETS AND THERAPY, 2019, 12 : 1937 - 1945
[24] Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
Guo, Rongqun
Lu, Mengdie
Cao, Fujiao
Wu, Guanghua
Gao, Fengcai
Pang, Haili
Li, Yadan
Zhang, Yinyin
Xing, Haizhou
Liang, Chunyan
Lyu, Tianxin
Du, Chunyan
Li, Yingmei
Guo, Rong
Xie, Xinsheng
Li, Wei
Liu, Delong
Song, Yongping
Jiang, Zhongxing
BIOMARKER RESEARCH, 2021, 9 (01)
[25] Immune escape and immunotherapy of acute myeloid leukemia
Vago, Luca
Gojo, Ivana
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04): : 1552 - 1564
[26] Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid Leukemia
Passaro, Diana
Di Tullio, Alessandro
Abarrategi, Ander
Rouault-Pierre, Kevin
Foster, Katie
Ariza-McNaughton, Linda
Montaner, Beatriz
Chakravarty, Probir
Bhaw, Leena
Diana, Giovanni
Lassailly, Franc Ois
Gribben, John
Bonnet, Dominique
CANCER CELL, 2017, 32 (03) : 324 - +
[27] Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment
Kogan, Aksinija A.
Lapidus, Rena G.
Baer, Maria R.
Rassool, Feyruz V.
CANCER STEM CELLS, 2019, 141 : 213 - 253
[28] The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies
Chandra, Daniel J.
Alber, Bernhard
Saultz, Jennifer N.
CANCERS, 2024, 16 (15)
[29] BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia
Li, Tushuai
Gao, Renjie
Xu, Kaiwen
Pan, Pengpeng
Chen, Congcong
Wang, Daokuan
Zhang, Keyi
Qiao, Jilei
Gu, Yue
DRUG RESISTANCE UPDATES, 2024, 76
[30] Elevated IL-35 in bone marrow of the patients with acute myeloid leukemia
Wang, Jia
Tao, Qianshan
Wang, Huiping
Wang, Zhitao
Wu, Fan
Pan, Ying
Tao, Lili
Xiong, Shudao
Wang, Yiping
Zhai, Zhimin
HUMAN IMMUNOLOGY, 2015, 76 (09) : 681 - 686

← 1 2 3 4 5 →